This Is What Whales Are Betting On Vertex Pharmaceuticals
Portfolio Pulse from Benzinga Insights
A significant bearish stance has been taken on Vertex Pharmaceuticals (NASDAQ:VRTX) by a large investor, as indicated by unusual options trades. The sentiment among these big-money traders is 27% bullish and 72% bearish. The whales have been targeting a price range from $340.0 to $370.0 for Vertex Pharmaceuticals over the last 3 months. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $370.
September 25, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A large investor has taken a bearish stance on Vertex Pharmaceuticals, indicating potential downward pressure on the stock.
The bearish stance taken by a large investor, as indicated by unusual options trades, suggests that there may be downward pressure on the stock in the short term. This is further supported by the fact that the sentiment among these big-money traders is largely bearish (72%).
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100